Mkts

Biogen Inc.

NASDAQ: BIIB
$250.79-0.86 (-0.34%)
As of Nov 17, 4:00 PM ET

Key statistics

Day range
248.27252.72
52-week range
160.36261.00
Today
Open248.97
Previous close250.79
Volume22.4K
Valuation
Market cap37.01B
P/E ratio106.51×
EPS (TTM)2.34
Income & risk
Dividend / yield—
Beta0.08
Avg volume1.12M
Discussion

BIIB News

Stories mentioning BIIB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,477,8002,279,4002,534,7002,645,5002,431,0002,454,7002,465,8002,464,900
Cost of Goods Sold661,000495,500674,400605,000629,300583,500638,700546,000
Gross Profit1,816,8001,783,9001,860,3002,040,5001,801,7001,871,2001,827,1001,918,900
Operating Expenses
Research & Development
Sales General & Admin607,300682,500594,800583,800572,500680,000588,400553,800
Total Operating Expenses
Operating Income (Loss)
Interest Income37,90037,20031,60032,30023,90018,50011,60020,100
Interest Expense67,60067,50067,40072,60060,00060,00059,80061,300
Other Expense(1,100)(39,700)15,800(3,300)2,5008,000(800.00)(2,000)
Pretax Income377,700(56,000)557,300744,000311,200291,500451,000698,700
Tax Provision58,200(7,100)90,800109,20070,70024,80062,500115,100
Net Income (Loss)319,500(48,900)466,500634,800240,500266,700388,500583,600
Earnings Per Share (Basic)2.17(0.33)3.184.331.651.832.674.01
Earnings Per Share (Diluted)2.15(0.33)3.174.331.641.832.664.00
Weighted Average Shares Outstanding (Basic)147,200146,500146,600146,500146,100145,600145,700145,600
Weighted Average Shares Outstanding (Diluted)148,400147,100147,100146,700146,600145,900146,100145,900

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BIIB

Biogen Inc. (NASDAQ: BIIB) is a stock listed on the Nasdaq Stock Market under the ticker symbol BIIB. It last traded at $250.79 (Nov 17, 2026, 4:00 PM ET), down 0.3% on the day. That gives Biogen a market capitalisation of $37.0B and a price-to-earnings ratio of 106.5.

Over the past 52 weeks BIIB has traded between $160.36 and $261.00.

Revenue for the quarter ended Mar 31, 2026 was $2.5B; net income $319.5M. Revenue was up 1.9% from $2.4B in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$2.5B$319.5M12.9%
Dec 31, 2025$2.3B-$48.9M-2.1%
Sep 30, 2025$2.5B$466.5M18.4%
Jun 30, 2025$2.6B$634.8M24.0%

From Biogen’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…